Source link : https://newshealth.biz/health-news/fda-oks-daraxonrasib-pancreatic-cancer-preapproval-access/
FDA authorizes an expanded access treatment protocol after the oral RAS(ON) inhibitor doubled survival for metastatic patients in a phase 3 trial. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-oks-daraxonrasib-pancreatic-cancer-preapproval-access-2026a1000e26?src=rss Author : Publish date : 2026-05-01 20:25:00 Copyright for syndicated content belongs to the linked Source.
The post FDA OKs Daraxonrasib Pancreatic Cancer Preapproval Access first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-01 20:25:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8